Instylla
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Burlington Rd, Bedford, Massachusett...Phone Number
(781) 790-4860Website
www.instylla.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Instylla
Instylla is a privately held company focused on developing peripheral liquid embolic products based on its proprietary hydrogel technology. Instylla is focused on embolization therapy in interventional radiology and oncology to improve patient outcomes, procedure efficiency, and enable new therapies. The company was founded by Incept LLC in 2017 and is headquartered in Bedford, MA.Explore more
Instylla Org Chart
RL
Chief Technology Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Instylla your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Instylla is spiking on competitors!
Check if Instylla has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Instylla launches new products
Instylla, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Instylla had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Instylla
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Instylla has new funding data
Earning: See what the market has to say on Instylla recently announced quarterly report
Recommended Actions
Find VP level buyers at Instylla
Find 2 more new buyers
Compare Similar Companies to Instylla
Compare insights from companies similar to Instylla, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Instylla is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Instylla is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Instylla.
Instylla financials insights
Gather financial insights about Instylla, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$8.1M
2020
Debt
$350K
Series B
$25.4M
2023
Private Equity
$30M
2025
Private Equity
$21.7M
Instylla Tech Stack
A closer look at the technologies used by Instylla
Most Recent Scoops
Lateral Move
Executive Move
Raymond Lareau has recently assumed the role of Chief Technology Officer.
Executive Moves, Lateral Move
Hiring Plans
Instylla has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Shipment Routing, Inventory Control, Good Manufacturing Practices, and Shipment Preparation.
Hiring Plans
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Instylla News & Media
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
First and Only Liquid Embolic Approved for Hypervascular Tumor Embolization Supported by a Prospective, Randomized, Controlled, Clinical Trial BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular...Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer
BEDFORD, Mass., Aug. 5, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Sean Boyle as Chief Executive Officer. I'm honored to join Instylla at such a crucial moment in...Instylla Announces the Appointment of Daniel Davis to Board of Directors
BEDFORD, Mass., April 15, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Daniel Davis to its Board of Directors. Mr. Davis is Chief Strategy Officer at Imperative...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Instylla
Sign Up For FreeTo access detailed company insights
Instylla is a privately held company focused on developing peripheral liquid embolic products based on its proprietary hydrogel technology. Instylla is focused on embolization therapy in interventional radiology and oncology to improve patient outcomes, procedure efficiency, and enable new therapies. The company was founded by Incept LLC in 2017 an... Read More
